A detailed history of First Horizon Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 178,469 shares of ABBV stock, worth $36.1 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
178,469
Previous 174,125 2.49%
Holding current value
$36.1 Million
Previous $34.4 Million 7.77%
% of portfolio
0.89%
Previous 0.96%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

BUY
$164.99 - $203.87 $716,716 - $885,611
4,344 Added 2.49%
178,469 $31.7 Million
Q3 2024

Nov 08, 2024

BUY
$163.84 - $199.33 $329,973 - $401,450
2,014 Added 1.17%
174,125 $34.4 Million
Q2 2024

Jul 19, 2024

BUY
$154.79 - $180.76 $201,846 - $235,711
1,304 Added 0.76%
172,111 $29.5 Million
Q1 2024

Apr 26, 2024

SELL
$159.82 - $182.1 $165,253 - $188,291
-1,034 Reduced 0.6%
170,807 $31.1 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $172,825 - $194,642
-1,256 Reduced 0.73%
171,841 $26.6 Million
Q3 2023

Oct 27, 2023

BUY
$133.59 - $154.65 $175,270 - $202,900
1,312 Added 0.76%
173,097 $25.8 Million
Q2 2023

Aug 03, 2023

BUY
$132.51 - $164.9 $107,465 - $133,733
811 Added 0.47%
171,785 $23.1 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $1.16 Million - $1.34 Million
8,043 Added 4.94%
170,974 $27.2 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $184,505 - $221,270
-1,334 Reduced 0.81%
162,931 $26.3 Million
Q3 2022

Nov 09, 2022

SELL
$134.21 - $153.93 $454,435 - $521,206
-3,386 Reduced 2.02%
164,265 $22 Million
Q2 2022

Aug 02, 2022

BUY
$137.62 - $174.96 $12.1 Million - $15.3 Million
87,643 Added 109.54%
167,651 $25.7 Million
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $14 Million - $17.4 Million
-105,978 Reduced 56.98%
80,008 $13 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $4,834 - $6,116
45 Added 0.02%
185,986 $25.2 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $1.41 Million - $1.6 Million
13,226 Added 7.66%
185,941 $20.1 Million
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $2.44 Million - $2.77 Million
22,898 Added 15.28%
172,715 $18.6 Million
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $425,784 - $474,348
4,047 Added 2.78%
149,817 $16.9 Million
Q1 2021

May 11, 2021

BUY
$102.3 - $112.62 $994,356 - $1.09 Million
9,720 Added 7.14%
145,770 $15.8 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $360,192 - $486,298
4,475 Added 3.4%
136,050 $14.6 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $337,282 - $395,858
3,926 Added 3.08%
131,575 $11.5 Million
Q2 2020

Jul 31, 2020

BUY
$73.37 - $98.18 $2.51 Million - $3.36 Million
34,196 Added 36.59%
127,649 $12.5 Million
Q1 2020

May 05, 2020

BUY
$64.5 - $97.79 $350,557 - $531,488
5,435 Added 6.17%
93,453 $7.12 Million
Q4 2019

Jan 07, 2020

BUY
$72.13 - $90.25 $126,155 - $157,847
1,749 Added 2.03%
88,018 $7.79 Million
Q3 2019

Oct 23, 2019

BUY
$62.98 - $75.72 $4.24 Million - $5.1 Million
67,397 Added 357.13%
86,269 $6.53 Million
Q2 2019

Aug 05, 2019

BUY
$65.7 - $83.98 $159,782 - $204,239
2,432 Added 14.79%
18,872 $0
Q1 2019

Apr 26, 2019

SELL
$77.14 - $90.79 $211,440 - $248,855
-2,741 Reduced 14.29%
16,440 $0
Q4 2018

Feb 11, 2019

SELL
$77.85 - $96.01 $146,591 - $180,786
-1,883 Reduced 8.94%
19,181 $1.77 Million
Q3 2018

Nov 05, 2018

BUY
$88.91 - $98.84 $1.81 Million - $2.01 Million
20,378 Added 2970.55%
21,064 $0
Q3 2018

Nov 05, 2018

SELL
$88.91 - $98.84 $1.81 Million - $2.01 Million
-20,311 Reduced 96.73%
686 $0
Q2 2018

Aug 07, 2018

BUY
$89.78 - $106.23 $1 Million - $1.19 Million
11,184 Added 113.97%
20,997 $0
Q1 2018

May 02, 2018

SELL
$92.01 - $123.21 $40,576 - $54,335
-441 Reduced 4.3%
9,813 $0
Q4 2017

Jan 25, 2018

BUY
$89.56 - $98.21 $308,175 - $337,940
3,441 Added 50.51%
10,254 $0
Q3 2017

Nov 09, 2017

SELL
$69.85 - $89.22 $11,525 - $14,721
-165 Reduced 2.36%
6,813 $0
Q2 2017

Aug 14, 2017

BUY
N/A
6,978
6,978 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $357B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.